mondoBIOTECH holding AG (SIX:RARE): United States FDA grants mondoBIOTECH’s Medicinal Product Candidate DasKloster0210 the Orphan Drug Designation for the treatment of Chronic Beryllium Disease

14 September 2010

Helsinn’s grant to support Eurordis Activities

9 September 2010

mondoBIOTECH holding AG (SIX:RARE): Presenting at BIOPHARM AMERICA 2010 in Boston

8 September 2010

Nautilus Neurosciences and APR Applied Pharma Research s.a. Announce Extension of Patent Protection for CAMBIA™ (diclofenac potassium for oral solution) through 2026

8 September 2010

mondoBIOTECH holding AG (SIX:RARE): Presenting at the Rodman & Renshaw 12th Annual Healthcare Conference

2 September 2010

Helsinn Chemical Operations is constantly becoming more environmentally friendly

2 September 2010

Helsinn announces the official opening of its new R&D centre of excellence in Dublin

1 September 2010

Assembly 2010

19 August 2010

The Association in figures

19 August 2010

Helsinn and Mundipharma sign new contract for Palonosetron in Asian countries

6 July 2010